BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28498568)

  • 1. Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.
    Karnell FG; Lin D; Motley S; Duhen T; Lim N; Campbell DJ; Turka LA; Maecker HT; Harris KM
    Clin Exp Immunol; 2017 Sep; 189(3):268-278. PubMed ID: 28498568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
    Abrahamsson SV; Angelini DF; Dubinsky AN; Morel E; Oh U; Jones JL; Carassiti D; Reynolds R; Salvetti M; Calabresi PA; Coles AJ; Battistini L; Martin R; Burt RK; Muraro PA
    Brain; 2013 Sep; 136(Pt 9):2888-903. PubMed ID: 23864273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
    Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological profiles of HIV-positive recipients of liver transplant.
    Righi E; Ivaldi F; La Rosa A; Carnelutti A; Londero A; Bassetti M
    Transpl Immunol; 2019 Dec; 57():101208. PubMed ID: 31102654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
    Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
    Front Immunol; 2018; 9():834. PubMed ID: 29867923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of naïve T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer.
    Mitra DK; Singh HP; Singh M; Alwadi A; Kochupillai V; Raina V; Kumar L; Mehra NK
    Transplantation; 2002 Apr; 73(8):1336-9. PubMed ID: 11981431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants.
    Rutella S; Rumi C; Laurenti L; Pierelli L; Sora' F; Sica S; Leone G
    Br J Haematol; 2000 Jan; 108(1):105-15. PubMed ID: 10651733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
    Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
    Darlington PJ; Touil T; Doucet JS; Gaucher D; Zeidan J; Gauchat D; Corsini R; Kim HJ; Duddy M; Jalili F; Arbour N; Kebir H; Chen J; Arnold DL; Bowman M; Antel J; Prat A; Freedman MS; Atkins H; Sekaly R; Cheynier R; Bar-Or A;
    Ann Neurol; 2013 Mar; 73(3):341-54. PubMed ID: 23463494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
    Arruda LCM; de Azevedo JTC; de Oliveira GLV; Scortegagna GT; Rodrigues ES; Palma PVB; Brum DG; Guerreiro CT; Marques VD; Barreira AA; Covas DT; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KCR
    Clin Immunol; 2016 Aug; 169():47-57. PubMed ID: 27318116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4
    Sacramento PM; Monteiro C; Dias ASO; Kasahara TM; Ferreira TB; Hygino J; Wing AC; Andrade RM; Rueda F; Sales MC; Vasconcelos CC; Bento CAM
    Eur J Immunol; 2018 Aug; 48(8):1376-1388. PubMed ID: 29719048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells.
    Tsukamoto H; Nagafuji K; Horiuchi T; Mitoma H; Niiro H; Arinobu Y; Inoue Y; To K; Miyamoto T; Iwasaki H; Teshima T; Harada M; Akashi K
    Rheumatology (Oxford); 2011 May; 50(5):944-52. PubMed ID: 21172925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Batorov EV; Tikhonova MA; Kryuchkova IV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Batorova DS; Gilevich AV; Ostanin AA; Shevela EY; Chernykh ER
    Int J Hematol; 2017 Jul; 106(1):108-115. PubMed ID: 28293817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reconstitution kinetics of T helper cells subsets post unmanipulated allogeneic blood and marrow transplantation].
    Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):745-50. PubMed ID: 24103870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
    Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
    Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.